Tetrahydrozoline hydrochloride, >=98%

Code: T4264-1G D2-231

Biochem/physiol Actions

Tetrahydrozoline is an α-adrenergic agonist and an imidazoline derivative. It plays a crucial role in the constriction of conjunctival blood vessels. ...


read more

Your Price
€65.84 1G
€80.98 inc. VAT

Biochem/physiol Actions

Tetrahydrozoline is an α-adrenergic agonist and an imidazoline derivative. It plays a crucial role in the constriction of conjunctival blood vessels. Tetrahydrozoline is a common component of nasal and eye drop formulations.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

1, 10 g in poly bottle

assay≥98% (HPLC)
Gene Informationhuman ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)
InChI keyBJORNXNYWNIWEY-UHFFFAOYSA-N
InChI1S/C13H16N2.ClH/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13;/h1-2,4,6,12H,3,5,7-9H2,(H,14,15);1H
originatorNovartis
Quality Level200
SMILES stringCl.C1CC(C2=NCCN2)c3ccccc3C1
solubilitychloroform: very slightly soluble, H2O: freely soluble, diethyl ether: insoluble, alcohol: freely soluble
Cas Number522-48-5
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.